Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Pfizer Inc. (4)
87 Articles Available
4
4
Can't find what you're looking for? Try our
advanced search
.
Priority Review
U.S., EU and Japan Health Authorities Accept Regulatory Submissions for Review of Pfizer’s Third-Generation ALK Inhibitor Lorlatinib
PR-M02-18-NI-52
Biosimilars
Pfizer Announces Positive Top-Line Results For Potential Biosimilar To Rituxan®/MabThera®
PR-M01-18-NI-092
CAR-T
Pfizer Joins Gilead in CAR-T Development
PAO-M01-18-NI-044
Development Agreement
Arvinas Protein Degradation Technology Attracts Pfizer’s Attention
PAO-M01-18-NI-020
Research
Pfizer Establishes New Partnering Model for Early-Stage Academic Research
PR-M01-18-NI-023
Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.
PR-M01-18-NI-014
Regulatory
FDA Approves New Pfizer Biosimilar
PR-M12-17-NI-010
Over-the-Counter
Men in the UK Will Be Able to Buy Viagra Over the Counter Next May
PAO-M12-17-NI-013
ADC
Pfizer Gets Second ADC Approval in 2017
PAO-M09-17-NI-019
Innovation
Post-Approval Studies Confirm Therapeutic Value of Oral Anticoagulants
PAO-M09-17-NI-005
ADC
Pfizer’s MYLOTARG Demonstrates Favorable Profile
PAO-M07-17-NI-022
Expansion
Pfizer Breaks New Ground in Missouri
PAO-M07-17-NI-003
FDA
FDA Fast Track Designation Granted for Pfizer and Eli Lilly’s Innovative Pain Treatment
PAO-M06-17-NI-010
Data Management
Keeping Track of Antibiotic Resistance Just Got Easier
PAO-M05-17-NI-031
Innovation
Pfizer Collaborates with Gene Editing Company Sangamo Therapeutics on Hemophilia A Treatment
PAO-M05-17-NI-022
«
4
4
.svg)
